CFAP410 and Down syndrome: Shim KS et al. found that C21orf2 was down-regulated in Down syndrome (DS) brain, which may represent mitochondrial dysfunction in DS patients38, while Cheon MS et al. pointed out that the expression level of C21orf2 was increased in fetal cerebral cortex from DS patients at 18–19 weeks of gestational age39.